UB-Licensed Technology Gains ‘Breakthrough’ Tag From FDA

Several news outlets reported on UB partner company Garwood Medical Devices, which has been granted a “Breakthrough Devices” designation that will expedite review of the company’s BioPrax device by the FDA. BioPrax, developed to treat biofilm infections on prosthetic knee implants, was created using technology licensed from UB. The electrical stimulation method that BioPrax uses was developed through a multidisciplinary collaboration between the labs of Mark Ehrensberger, PhD, associate professor of biomedical engineering, and Anthony A. Campagnari, PhD, SUNY Distinguished Professor of microbiology and immunology.